Chromosome 1 trisomy confers resistance to aureobasidin A in Candida albicans

Front Microbiol. 2023 Mar 17:14:1128160. doi: 10.3389/fmicb.2023.1128160. eCollection 2023.

Abstract

Introduction: Candida albicans is a prevalent opportunistic human fungal pathogen. However, there are currently very few antifungal treatments available. Inositol phosphoryl ceramide synthase is an essential and fungal-specific protein that also provides a novel and promising antifungal target. Aureobasidin A is a widely used inhibitor of inositol phosphoryl ceramide synthase, however the mechanism of resistance to aureobasidin A is largely unknown in pathogenic fungi.

Methods: Here we investigated how C. albicans adapted to low and high concentrations of aureobasidin A.

Results and discussions: We identified trisomy of chromosome 1 as the predominant mechanism of rapid adaptation. Resistance to aureobasidin A was unstable because of the inherent instability of aneuploids. Importantly, chromosome 1 trisomy simultaneously regulated genes which were associated with aureobasidin A resistance that are on this aneuploid chromosome as well as on other chromosomes. Furthermore, the pleiotropic effect of aneuploidy caused altered resistance not only to aureobasidin A but also to other antifungal drugs including caspofungin and 5-flucytosine. We posit aneuploidy provides a rapid and reversible mechanism of development of drug resistance and cross resistance in C. albicans.

Keywords: Candida albicans; aneuploidy; antifungal drugs; aureobasidin A; sphingolipid biosynthesis.

Grants and funding

This study was supported by the Science and Technology Development Plan of Suzhou (SLJ2022018), Scientific Research Project of Suzhou Commission of Health (GSWS2020028) to LG, and the National Natural Science Foundation of China (81402978) to YX.